A single dose of Johnson & Johnson’s experimental COVID-19 vaccine produced a strong immune response against the new coronavirus in an early to mid-stage clinical trial, according to interim results released Friday. The vaccine, called Ad26.COV2.S, was equally well tolerated at two different doses, the results showed. A single injection, …
Read More »Johnson & Johnson Covid-19 Vaccine Produces Strong Immune Response in Initial Trial
